跳转至内容
Merck
CN
  • New selective inhibitors of steroid 11beta-hydroxylation in the adrenal cortex. Synthesis and structure-activity relationship of potent etomidate analogues.

New selective inhibitors of steroid 11beta-hydroxylation in the adrenal cortex. Synthesis and structure-activity relationship of potent etomidate analogues.

Journal of medicinal chemistry (2008-03-20)
Ilse M Zolle, Michael L Berger, Friedrich Hammerschmidt, Stefanie Hahner, Andreas Schirbel, Biljana Peric-Simov
摘要

Derivatives of etomidate were evaluated as inhibitors of adrenal steroid 11beta-hydroxylations. Stereoselective coupling by Mitsunobu produced chirally pure analogues to study the effect of configuration, modification of the ester, and substitution in the phenyl ring, with the aim to probe specific sites for introducing a radionuclide. Iodophenyl metomidate (IMTO) labeled with iodine-131 served as radioligand for structure-affinity relationship studies. We have characterized the kinetic parameters of specific (131)I-IMTO binding on rat adrenal membranes and used the displacement of (131)I-IMTO binding to evaluate functionalized MTO analogues. Our results indicated that (1) ( R)-configuration is essential for high affinity, (2) highest potency resides in the ethyl, 2-propyl, and 2-fluoroethyl esters, and (3) substitution of the phenyl ring is well tolerated. The clinically used inhibitors metyrapone and ketoconazole inhibited (131)I-IMTO binding with low affinity. Incubation of selected analogues with human adrenocortical NCI-h295 cells demonstrated a high correlation with the inhibitory effect on cortisol secretion.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
酮康唑, 99.0-101.0% (EP, titration)
Sigma-Aldrich
21-Hydroxyprogesterone, ≥97% (HPLC)
Sigma-Aldrich
2-甲基-1,2-二-3-吡啶基-1-丙酮, 96%